Menu Search
Equities

Beijing Kawin Technology Share-Holding Co Ltd

688687:SHH

Beijing Kawin Technology Share-Holding Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)28.76
  • Today's Change-0.48 / -1.64%
  • Shares traded4.99m
  • 1 Year change-2.77%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Beijing Kawin Technology Share-Holding Co Ltd grew revenues 21.73% from 1.16bn to 1.41bn while net income improved 39.71% from 83.41m to 116.52m.
Gross margin81.80%
Net profit margin11.31%
Operating margin13.85%
Return on assets6.49%
Return on equity7.57%
Return on investment8.52%
More ▼

Cash flow in CNYView more

In 2023, Beijing Kawin Technology Share-Holding Co Ltd increased its cash reserves by 10.46%, or 75.38m. The company earned 126.60m from its operations for a Cash Flow Margin of 8.97%. In addition the company generated 8.92m cash from financing while 61.03m was spent on investing.
Cash flow per share--
Price/Cash flow per share--
Book value per share10.87
Tangible book value per share9.68
More ▼

Balance sheet in CNYView more

Beijing Kawin Technology Share-Holding Co Ltd appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 807.72m.
Current ratio3.11
Quick ratio2.91
Total debt/total equity0.1686
Total debt/total capital0.141
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 25.00% and 42.86%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)31.16%
EPS growth(5 years)13.56
EPS (TTM) vs
TTM 1 year ago		30.08
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.